Literature DB >> 19915814

Synergism between pyronaridine and retinol in Plasmodium falciparum in vitro.

Pippa Proell1, Kanungnit Congpuong, Franz F Reinthaler, Gunther Wernsdorfer, Ursula Wiedermann, Walther H Wernsdorfer.   

Abstract

Pyronaridine, a naphthyridine derivative and Mannich base, is a highly active blood schizontocide and currently being explored as partner in artemisinin-based combination therapy (ACT). In this study, carried out 2008 in Mae Sot, Thailand, the activity of pyronaridine was found to be compromised, obviously as the result of mono-therapy in an adjacent area. The pyronaridine sensitivity and the interaction between pyronaridine and retinol at concentrations corresponding to the 50th, 65th and 80th percentile of the physiological retinol levels in healthy adults were assessed in 38 fresh isolates of P. falciparum. The mean IC50, IC90 and IC99 values for pyronaridine were 12.7, 201.4 and 3084.2 nM, those for pyronaridine + retinol "low" 1.2, 14.0 and 102.6 nM, those for pyronaridine + retinol "medium" 0.6, 7.4 and 54.8 nM, and those for pyronaridine + retinol "high" 0.9, 8.2 and 47.8 nM. There was significant evidence of strong synergism between pyronaridine and retinol against P. falciparum.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19915814     DOI: 10.1007/s00508-009-1232-5

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  18 in total

1.  A simplified method of evaluating dose-effect experiments.

Authors:  J T LITCHFIELD; F WILCOXON
Journal:  J Pharmacol Exp Ther       Date:  1949-06       Impact factor: 4.030

2.  In vitro activity of artemisinin alone and in combination with retinol against Plasmodium falciparum.

Authors:  Kamala Thriemer; Gunther Wernsdorfer; Chaiporn Rojanawatsirivet; Herwig Kollaritsch; Jeeraphat Sirichainsinthop; Walther H Wernsdorfer
Journal:  Wien Klin Wochenschr       Date:  2005       Impact factor: 1.704

3.  [Development of pyronaridine-resistance in Plasmodium berghei].

Authors:  B R Shao; X Y Ye; H Zheng
Journal:  Yao Xue Xue Bao       Date:  1982-08

4.  [Synthesis of new antimalarial drug pyronaridine and its analogues (author's transl)].

Authors:  X Y Zheng; C Chen; F H Gao; P E Zhu; H Z Guo
Journal:  Yao Xue Xue Bao       Date:  1982-02

5.  A method for testing for synergy with any number of agents.

Authors:  M C Berenbaum
Journal:  J Infect Dis       Date:  1978-02       Impact factor: 5.226

6.  In vitro activities of pyronaridine, alone and in combination with other antimalarial drugs, against Plasmodium falciparum.

Authors:  P Ringwald; E C Eboumbou; J Bickii; L K Basco
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

7.  Plasma alpha-tocopherol, retinol, and carotenoids in children with falciparum malaria.

Authors:  B S Das; D I Thurnham; D B Das
Journal:  Am J Clin Nutr       Date:  1996-07       Impact factor: 7.045

8.  Malaria is associated with reduced serum retinol levels in rural Zambian children.

Authors:  J L Hautvast; J J Tolboom; C E West; E M Kafwembe; R W Sauerwein; W A van Staveren
Journal:  Int J Vitam Nutr Res       Date:  1998       Impact factor: 1.784

9.  Characterization of the effect of retinol on Plasmodium falciparum in vitro.

Authors:  J Hamzah; T M E Davis; T S Skinner-Adams; J Beilby
Journal:  Exp Parasitol       Date:  2004 Jul-Aug       Impact factor: 2.011

10.  Synergism between quinine and retinol in fresh isolates of Plasmodium falciparum.

Authors:  Ariane Knauer; Kanungnit Congpuong; Gunther Wernsdorfer; Franz F Reinthaler; Jeeraphat Sirichaisinthop; Walther H Wernsdorfer
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

View more
  1 in total

1.  Synergism between pyronaridine and retinol in Plasmodium vivax in vitro.

Authors:  Julia Riedl; Gunther Wernsdorfer; Kanungnit Congpuong; Ursula Wiedermann; Jeeraphat Sirichaisinthop; Walther H Wernsdorfer
Journal:  Wien Klin Wochenschr       Date:  2010-10       Impact factor: 1.704

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.